Arduini Peter J
Transaction: 06/30/2026
BUY
Change
—
Price
Not reported
Filing
07/02/2026
Type
BUY
Bristol-Myers Squibb Company PFD CONV 2
BMYMP • Drug Manufacturers - General
$66.82
▼ -1.27 (-1.87%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$814.59B
Growth
5.1%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 14.6%Positive free cash flow · 6.29Consistent free cash flow · 5/5Reasonable earnings multiple · 15.61High debt level · 2.55
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$66.82
Change-1.87%
Market Cap$814.59B
52W Range400.00 - 1050.00
Beta0.27
Gross Margin67.65%
Oper. Margin26.34%
Profit Margin14.63%
Debt/Eq2.55
Current Ratio1.26
Quick Ratio1.14
Revenue 5Y5.12%
Price$66.82
Change-1.87%
Market Cap$814.59B
52W Range400.00 - 1050.00
Beta0.27
Gross Margin67.65%
Oper. Margin26.34%
Profit Margin14.63%
Debt/Eq2.55
Current Ratio1.26
Quick Ratio1.14
Revenue 5Y5.12%
Target$63.25
Target Upside-5.34%
Target Median$65.00
Target Range40.00 - 75.00
Volume13.00
Avg Volume2.00
EPS Surprise0.16
Investment DNA
How strong this company looks for long-term investors
74
out of 100
Business Quality
Margins, moat, returns
81/100
Financial Strength
Debt, cash, stability
61/100
Growth Potential
Revenue and expansion
36/100
Price Attractiveness
Cheap or expensive today
78/100
Why this score▼
Stable or improving margins · 14.6%Positive free cash flow · 6.29Consistent free cash flow · 5/5Reasonable earnings multiple · 15.61High debt level · 2.55Negative growth trend
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-31
Low
$40.00
Mean
$63.25
Median
$65.00
High
$75.00
Insider Transactions
Recent executive and insider activity
McMullen Michael R.
Transaction: 06/30/2026
BUY
Change
—
Price
Not reported
Filing
07/02/2026
Type
BUY
Rice Derica W
Transaction: 06/30/2026
BUY
Change
—
Price
Not reported
Filing
07/02/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Arduini Peter J | BUY | — | Not reported | 06/30/2026 | 07/02/2026 |
| McMullen Michael R. | BUY | — | Not reported | 06/30/2026 | 07/02/2026 |
| Rice Derica W | BUY | — | Not reported | 06/30/2026 | 07/02/2026 |
| Samuels Theodore R. II | BUY | — | Not reported | 06/30/2026 | 07/02/2026 |
| YALE PHYLLIS R | BUY | — | Not reported | 06/30/2026 | 07/02/2026 |
| Haller Julia A | SELL | -20,460 | $53.76 | 06/15/2026 | 06/16/2026 |
| Haller Julia A | BUY | +20,460 | $53.76 | 06/15/2026 | 06/16/2026 |
| Short Bartie Wendy | SELL | -8,040 | Not reported | 06/03/2026 | 06/05/2026 |
| Short Bartie Wendy | SELL | -3,876 | $54.72 | 06/03/2026 | 06/05/2026 |
| Lenkowsky Adam | SELL | -1,373 | Not reported | 05/01/2026 | 05/05/2026 |
| Lenkowsky Adam | SELL | -599 | $58.22 | 05/01/2026 | 05/05/2026 |
| Elkins David V | SELL | -4,481 | $62.05 | 04/01/2026 | 04/02/2026 |
| Shanahan Karin | SELL | -3,307 | Not reported | 04/01/2026 | 04/02/2026 |
| Shanahan Karin | SELL | -1,692 | $61.73 | 04/01/2026 | 04/02/2026 |
| Arduini Peter J | BUY | — | Not reported | 03/31/2026 | 04/02/2026 |
| McMullen Michael R. | BUY | — | Not reported | 03/31/2026 | 04/02/2026 |
| Rice Derica W | BUY | — | Not reported | 03/31/2026 | 04/02/2026 |
| Samuels Theodore R. II | BUY | — | Not reported | 03/31/2026 | 04/02/2026 |
| YALE PHYLLIS R | BUY | — | Not reported | 03/31/2026 | 04/02/2026 |
| Elkins David V | SELL | -7,654 | Not reported | 03/10/2026 | 03/12/2026 |